Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · Real-Time Price · USD

76.94

-1.12 (-1.43%)

At close: May 22, 2026, 4:00 PM EDT

76.42

-0.52 (-0.67%)

After-hours: May 22, 2026, 7:38 PM EDT

Cytokinetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	129.84	122.52	94.86	113.02	65.58	112.67
Short-Term Investments	688.71	759.7	981.16	501.8	717	358.97
Cash & Short-Term Investments	818.55	882.22	1,076	614.82	782.58	471.64
Cash Growth	-12.75%	-18.01%	75.01%	-21.44%	65.93%	1.63%
Accounts Receivable	6.83	17.76	16.65	1.28	0.15	51.82
Inventory	0.15	-	-	-	-	-
Other Current Assets	13.93	16.99	15.28	11.94	12.46	12.22
Total Current Assets	839.47	916.98	1,108	628.05	795.19	535.67
Net Property, Plant & Equipment	156.98	155.17	140.97	147.74	163.19	146.41
Long-Term Investments	254.72	335.05	145.06	40.53	46.71	152.05
Other Long-Term Assets	22.31	17.34	7.71	8	9.69	7.19
Total Assets	1,273	1,425	1,402	824.32	1,015	841.32
Accounts Payable	24.71	22.34	20.37	21.51	25.61	21.09
Accrued Expenses	68.86	83.28	55.32	42.64	44.1	34.37
Current Portion of Long-Term Debt	44.81	41.18	11.52	10.08	0.96	-
Current Portion of Leases	20.96	19.11	18.98	17.89	12.83	14.86
Unearned Revenue	1.65	1.61	52.37	-	-	-
Other Current Liabilities	38.19	34.93	21.11	10.56	1.12	1.54
Total Current Liabilities	199.19	202.45	179.67	102.68	84.62	71.86
Long-Term Debt	1,118	1,116	645.6	607.37	609.62	142.84
Long-Term Leases	105.24	107.97	112.58	120.43	126.9	112.23
Other Long-Term Liabilities	677.91	657.76	599.19	380.16	301.55	270.53
Total Long-Term Liabilities	1,901	1,882	1,357	1,108	1,038	525.6
Total Liabilities	2,100	2,084	1,537	1,211	1,123	597.46
Common Stock	0.12	0.12	0.12	0.1	0.09	0.08
Additional Paid-in Capital	2,868	2,826	2,564	1,726	1,482	1,452
Accumulated Other Comprehensive Income	-1.61	0.63	2.4	-0.01	-3.59	-0.87
Retained Earnings	-3,693	-3,487	-2,702	-2,112	-1,586	-1,208
Shareholders' Equity	-826.57	-659.63	-135.37	-386.32	-107.9	243.86
Total Liabilities & Equity	1,273	1,425	1,402	824.32	1,015	841.32
Total Debt	1,289	1,284	788.68	755.77	750.3	269.93
Net Cash (Debt)	-470.17	-402.02	287.34	-140.95	32.28	201.71
Net Cash Growth	-	-	-	-	-84.00%	-37.96%
Net Cash Per Share	-3.88	-3.35	2.57	-1.46	0.36	2.62
Book Value	-826.57	-659.63	-135.37	-386.32	-107.9	243.86
Book Value Per Share	-6.82	-5.49	-1.21	-4.00	-1.20	3.17
Tangible Book Value	-826.57	-659.63	-135.37	-386.32	-107.9	243.86
Tangible Book Value Per Share	-6.82	-5.49	-1.21	-4.00	-1.20	3.17

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q